Augmented lipopolysaccharide-induced TNF-alpha production by peritoneal macrophages in type 2 diabetic mice is

Christina L Sherry1, Jason C O'Connor, Jason M Kramer

  • 1Division of Nutritional Sciences, Integrative Immunology and Behavior Program, University of Illinois, 506 South Mathews Avenue, Urbana, IL 61801, USA.

Insights

Type 2 diabetes (T2D) increases inflammation. High glucose in T2D elevates lipopolysaccharide (LPS)-induced TNF-alpha production in macrophages, requiring p38 MAPK activation for this inflammatory response.

Area of Science:

  • Immunology
  • Endocrinology
  • Molecular Biology

Background:

  • Dysregulated inflammation is a key complication in type 2 diabetes (T2D).
  • Macrophages play a central role in inflammatory processes.
  • Understanding the molecular mechanisms driving inflammation in T2D is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the mechanisms behind augmented lipopolysaccharide (LPS)-induced TNF-alpha production in macrophages from type 2 diabetic mice.
  • To determine the role of elevated glucose and specific signaling pathways, such as p38 MAPK, in this process.

Main Methods:

  • Comparison of TNF-alpha production in response to LPS between peritoneal macrophages (PerMphi) from type 2 diabetic (db/db) mice and non-diabetic (db/+) mice.
  • Ex vivo stimulation of PerMphi with LPS in varying glucose concentrations.
  • Analysis of signaling pathway activation (PI3K, ERK1/2, p38 MAPK) and the effect of p38 kinase inhibition.

Main Results:

  • db/db mice exhibited significantly higher LPS-induced TNF-alpha production in both peritoneal fluid and serum compared to db/+ mice.
  • PerMphi from db/+ mice cultured in high glucose showed increased TNF-alpha production upon LPS stimulation.
  • LPS-induced p38 MAPK activation was significantly greater in PerMphi from db/db mice, and its inhibition abolished TNF-alpha production.

Conclusions:

  • Augmented TNF-alpha production in macrophages during diabetes is primarily driven by hyperglycemia.
  • The p38 MAPK pathway is essential for the increased inflammatory response to LPS in the context of type 2 diabetes.
  • These findings highlight the link between hyperglycemia, macrophage activation, and inflammation in T2D.

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...